Pharm
Sumatriptan
search
Sumatriptan
, Sumatriptan Succinate, Imitrex, Treximet
See Also
Triptan
Migraine Abortive Treatment
Triptan Overdose
Indications
Gene
ral
Migraine Abortive Treatment
(adults)
Intranasal form has been used off-label for age >8 years
Cluster Headache
(subcutaneous form)
Controversial cohorts in whom
Triptan
use is now thought safe (
Cardiovascular Risk Factor
s)
Controlled
Diabetes Mellitus
Controlled
Hypertension
Controlled
Hyperlipidemia
Postmenopausal women
Men over age 40 years
Contraindications
Severe hepatic
Impairment
Coronary Artery Disease
Prinzmetal's Angina
Uncontrolled Hypertension
Basilar Artery
Migraine
Familial Hemiplegic
Migraine
Ischemic
Cerebrovascular Accident
Pregnancy
Concurrent Medication use (absolute contraindications)
MAO Inhibitor
use
Ergotamine
use in prior 24 hours
Mechanism
Serotonergic
5-HT
1 receptor
Agonist
s
Inhibits sensory dural nerve fiber neuropeptide release
Intracranial extracerebral artery
Vasocon
striction
Mediated by
Triptan
direct effect on cerebrovascular
Smooth Muscle
Precautions
Screen for cardiovascular disease before use!
Limit to no more than twice weekly
Medications
Sumatriptan (Imitrex)
Oral 25 mg, 50 mg, 100 mg
Gene
ric dosing may be as low as $3/dose
Intranasal forms
Intranasal Imitrex: 5 mg, 20 mg (box of 6)
Intranasal Tosymra: 10 mg
Intranasal Onzetra Xsail: 11 mg powder
Even generic dosing approaches $100/dose
Subcutaneous Injection
s
Subcutaneous Imitrex Injection: 6 mg prefilled syringe cartridges (box of 4)
Subcutaneous Zembrace SymTouch 3 mg autoinjector
Treximet (combination with
Naproxen
)
Contains Sumatriptan 85 mg with
Naproxen
500 mg
Released as Sumatriptan becomes generically available
Cheaper to purchase generic Sumatriptan (when available) and
Naproxen
separately
Contraindicated in eGFR <30 ml/min
Zecurity patch (listed for historical reasons only)
Removed from market 2016 due to serious adverse effects including burns
http://www.fda.gov/Drugs/DrugSafety/ucm504588.htm
Dosing
Limit to use in adults
Intranasal form has been used off-label for age >8 years
Subcutaneous Sumatriptan
Initial: 6 mg SC
May repeat in 1 hour if no effect with first dose
Doses of 1-5 mg may be used if 6 mg is not tolerated
If
Headache
returns, may switch to oral tablets, giving 25 mg every 2 hours (max 100 mg in 24 hours)
Maximum: 12 mg/day
Do NOT give IM or IV (use only SQ)
Oral Sumatriptan
Dose 25 to 100 mg orally every 2 hours as needed
Start at 50 to 100 mg for first oral dose for best efficacy in young adult without contraindications
Maximum: 200 mg in 24 hours
Adjust for hepatic
Impairment
Mild to moderate hepatic
Impairment
: Limit maximum dose to 50 mg
Severe hepatic
Impairment
: Avoid oral Sumatriptan
Oral Treximet
Adults
Take 1 tablet (85/500 mg) orally at
Migraine
onset
May repeat once in 2 hours
Maximum: 2 tabs in 24 hours
Limit to one 10/60 mg in mild to moderate hepatic
Impairment
(and avoid in severe hepatic
Impairment
)
Child age >12 years
Give 1 tablet (10/60 mg) orally at
Migraine
onset
Maximum: 1 tablet (85/500 mg) in 24 hours
Intranasal Sumatriptan
Initial: 5, 10 or 20 mg intranasal
Dose responsive (20 mg most effective)
Repeat after 2 hours as needed
Maximum: 40 mg in 24 hours
Safety of use in over 4
Headache
s per month not known
Although FDA approved only for adults, Intranasal form has been used off-label for age >8 years
Weight 20 to 39 kg: 10 mg intranasally at
Headache
onset, and may repeat once in 2 hours
Weight >40 kg: 20 mg intranasally at
Headache
onset, and may repeat once in 2 hours
Adverse Effects
See
Triptan Overdose
Injection (e.g. Sumatriptan)
Tingling,
Flushing
or burning
Sensation
at injection sites
Intranasal preparations
Dysgeusia
(Terrible taste)
Vasospasm
Gene
rally benign in low risk populations
Avoid in
Coronary Artery Disease
,
Cerebrovascular Disease
,
Peripheral Arterial Disease
Also avoid in hemiplegic
Migraine
or basilar
Migraine
Medication Overuse Headache
s
Highest risk with >10 doses per month
Limit to two doses weekly
Safety
Unknown safety in
Lactation
Pregnancy Category C (most
Triptan
s, but generally avoided in pregnancy)
See
Migraine Medications in Pregnancy
Not recommended for routine use in pregnancy
Avoid Treximet in pregnancy overall (contains
Naproxen
)
Consult obstetrics before use
May be considered if
Migraine
s are uncontrolled, debilitating
If used, Sumatriptan has the longest safety data
Adverse effects in pregnancy
Avoid in first trimester (fetal malformations and adverse pregnancy outcomes)
Risk of uterine atony and peripartum
Hemorrhage
(but may be considered in debilitating
Headache
)
Associated with hyperactivity and emotionality at age 3 in exposed children (AHRQ)
References
Nezvalova-Henriksen (2010) Headache 50(4): 563-75 +PMID: 20132339 [PubMed]
Drug Interactions
See absolute contraindications above
Ergotamine
MAO Inhibitor
s
Lithium
Selective Serotonin Reuptake Inhibitor
(
SSRI
)
Risk of
Serotonin Syndrome
when combined with
SSRI
,
SNRI
or
MAO Inhibitor
s
Efficacy
Sumatriptan
Efficacy dependent on mode of drug delivery
Subcutaneous effective in 80% of patients
Intranasal effective in 70% of patients
Oral effective in 60% of patients
Oral form does not prevent
Migraine
recurrence
Rapoport (1995) Neurology 45:1505-9 [PubMed]
Management
Overdose
or Toxicity
See
Triptan Overdose
Resources
Sumatriptan Tablet (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=121e36fb-471b-4318-bc47-b087ad68c6f7
Sumatriptan Nasal Spray (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f
Sumatriptan Injection Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b1bb8c9-be3a-47c3-b3bc-9c983cde7d23
Treximet (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42ddf376-8dc0-4236-be2a-0c6ae92ece04
Triptan
s (StatPearls)
https://www.ncbi.nlm.nih.gov/books/NBK554507/
Where do
Triptan
s act in the treatment of
Migraine
? (PMC)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850935/
References
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Jamieson (2002) Am J Med 112:138 [PubMed]
Ahn (2005) Pain 115(1-2):1-4 +PMID: 15836963 [PubMed]
Type your search phrase here